Ascendis Pharma A/S Net Deferred Tax Assets
Ascendis Pharma A/S (ASND) had Net Deferred Tax Assets of -EUR 9.62 million as of 2025-12-31, per its 20-F filed 2026-02-11.
Financial Statements › Notes › Income Taxes
ifrs-full:NetDeferredTaxAssets · last filed 2026-02-11
- 2025-12-31: Net Deferred Tax Assets -9.62M EUR.
- 2024-12-31: Net Deferred Tax Assets -7.26M EUR.
- 2023-12-31: Net Deferred Tax Assets -5.83M EUR.
- 2021-12-31: Net Deferred Tax Assets 0.00 EUR.
| Period end | Net Deferred Tax Assets |
|---|---|
| 2025-12-31 | -9.62M EUR 20-F · filed 2026-02-11 |
| 2024-12-31 | -7.26M EUR 20-F · filed 2026-02-11 |
| 2023-12-31 | -5.83M EUR 20-F · filed 2026-02-11 |
| 2021-12-31 | 0.00 EUR 20-F · filed 2022-03-02 |
| 2020-12-31 | 0.00 EUR 20-F · filed 2022-03-02 |
| 2019-12-31 | 0.00 EUR 20-F · filed 2022-03-02 |
| 2018-12-31 | 0.00 EUR 20-F · filed 2021-03-10 |
| 2017-12-31 | 0.00 EUR 20-F · filed 2020-04-03 |
| 2016-12-31 | 0.00 EUR 20-F · filed 2019-04-03 |